Pharmaceutical companies have been working hard to make drugs to elbow out warfarin as the stroke-prevention drug for 2.3 million Americans with atrial fibrillation. A new study finds one of the contenders, rivaroxaban, is as effective as warfarin in
Read More...
Read the complete post at http://www.npr.org/blogs/health/2011/08/10/139402588/for-stroke-prevention-a-new-alternative-to-warfarin?ft=1&f=103537970
Posted
Aug 10 2011, 03:30 PM
by
NPR Blogs: Shots - Health Blog